"You can hide it if you want to, you can let it be seen if you want to": A qualitative study of the lived experiences of australian adults with type 1 diabetes using the Omnipod DASH® system.

Stocco, Amber; Trawley, Steven; Kong, Yee Wen; Yuan, Cheng Yi; Kiburg, Katerina; Pham, Cecilia; Brown, Katrin; Partovi, Andi; Roem, Kerryn; Harrison, Natalie; Fourlanos, Spiros; Ekinci, Elif I; O'Neal, David N

doi:10.1016/j.diabres.2024.111123

Title

"You can hide it if you want to, you can let it be seen if you want to": A qualitative study of the lived experiences of australian adults with type 1 diabetes using the Omnipod DASH® system.

Publication Date

2024-02-01

Author(s)

Stocco, Amber

Trawley, Steven

Kong, Yee Wen

Yuan, Cheng Yi

Kiburg, Katerina

Pham, Cecilia

Brown, Katrin

Partovi, Andi

Roem, Kerryn

Harrison, Natalie

Fourlanos, Spiros

Ekinci, Elif I

O'Neal, David N

Subject

Insulin pump

Interviews

Type 1 diabetes

Type of document

Journal Article

OrcId

#PLACEHOLDER_PARENT_METADATA_VALUE#

DOI

10.1016/j.diabres.2024.111123

Abstract

Understanding the lived experience of using a tubeless insulin pump and how this differs compared to usual care (tubed insulin pump therapy (IPT) vs multiple daily injections (MDI)). Interviews were conducted after 12-weeks of using the Omnipod DASH Insulin Management System (Insulet, Acton, MA) and analysed using thematic analysis. Fifty-eight adults (35 female; mean age 42;SD 13 years; 35 previous MDI) were interviewed. Most (84 %) wanted to continue using the device. Experiences fit two themes: 1. Taking back control of my diabetes: many previous MDI users perceived improved glycaemic control, explained by more "nuanced" control, with some reporting positive effects during exercise and sleep. Many previous MDI and IPT users endorsed positive experiences in concealing or disclosing their diabetes to others. However, some previous MDI users reported negative psychosocial experiences due to feeling continuously "attached" to their diabetes. 2. Barriers and facilitators of device acceptability: both MDI and IPT users cited wearability, alarms and the financial cost impacted their choice to continue device use. IPT users reported positive wearability experiences. The tubeless pump improved diabetes management perceptions for both MDI and tubed pump users. However, participants' prior glucose management affected perceptions of its advantages and disadvantages.

Link

link

Citation

Diabetes Research and Clinical Practice 2024-02-01

Jornal Title

Diabetes Research and Clinical Practice

ISSN

1872-8227

Austin Health

Files: